PROgram To Enhance Cardiovascular Risk Trough an Intervention of Nutrition in Bipolar Disorder
PROTECTION-BD
The Effect of a Nutritional Intervention Focused on Dietary Pattern in the Cardiovascular Risks of Individuals With Bipolar Disorder
1 other identifier
interventional
88
1 country
1
Brief Summary
Individuals with Bipolar Disorder (BD) have twice the risk of being affected by metabolic comorbidities and a 1.8-fold increased risk of mortality from cardiovascular diseases when compared to the general population. These factors are fundamental in the 14-year reduction in the life expectancy of people with TB reported in recent meta-analyses. This occurs mainly due to the increased inflammation associated with the disease, the adverse effects of pharmacological treatments and unhealthy lifestyle habits that are more common in people diagnosed with BD. Nutrition has been studied as an adjunctive treatment in other psychiatric disorders, but there is a lack of studies about the role of nutrition in TB. Considering that diet can impact metabolic health, this randomized controlled study aims to evaluate the effect of a nutritional intervention on cardiovascular risk in patients with TB. The intervention is based on the dietary pattern recommended in the Dietary Guidelines for the Brazilian Population and will be applied by a registered dietitian. According to the literature, the sample size will be 72 individuals with TB (36 in the control group with usual treatment + 36 in the intervention group added to the usual treatment). The intervention will be carried out in 7 individual sessions and 8 group sessions with specific themes. The primary aim of this protocol will be an intervention to contribute to cardiovascular health - verified by serum markers, anthropometric measurements and the Framingham Cardiovascular Risk Score (algorithm used to estimate an individual's 10-year cardiovascular risk). The secondary stages will be the adherence of the intervention and the impact on the quality of life of the participants. The possible positive results of this nutritional intervention can open new clinical perspectives. Meaning that might show that better food choices can protect the cardiovascular health of individuals with TB, leading to a reduction in morbidity and mortality associated with the disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 17, 2024
CompletedFirst Posted
Study publicly available on registry
July 5, 2024
CompletedStudy Start
First participant enrolled
April 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
March 2, 2026
February 1, 2026
7 months
June 17, 2024
February 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (11)
C reactive protein
C reactive protein
Baseline, week 12, week 24 and follow up at week 52
Total cholesterol and fractions
Total cholesterol and fractions
Baseline, week 12, week 24 and follow up at week 52
Glycemia
Glycemia
Baseline, week 12, week 24 and follow up at week 52
Glycated hemoglobin A1C
Glycated hemoglobin A1C
Baseline, week 12, week 24 and follow up at week 52
Triglycerides
Triglycerides
Baseline, week 12, week 24 and follow up at week 52
HOMA IR
HOME IR
Baseline, week 12, week 24 and follow up at week 52
Apoliporpotein B
Apoliporpotein B
Baseline, week 12, week 24 and follow up at week 52
Cardiovascular risk
Framingham Global Risk Score (-3 to 21; higher scores mean worse outcome)
Baseline, week 12, week 24 and follow up at week 52
Body weight
Body weight
Baseline, week 12, week 24 and follow up at week 52
Body fat percentage
Body fat percentage
Baseline, week 12, week 24 and follow up at week 52
waist circumference
waist circumference
Baseline, week 12, week 24 and follow up at week 52
Secondary Outcomes (4)
Dietary assessment - dietary intake
Baseline, week 12, week 24 and follow up at week 52
Dietary assessment - dietary quality
Baseline, week 12, week 24 and follow up at week 52
Dietary assessment - dietary adehrence
Baseline, week 12, week 24 and follow up at week 52
Quality of life WHOQOL
Baseline, week 12, week 24 and follow up at week 52
Study Arms (2)
Treatment as usual
NO INTERVENTIONTreatment as usual
Nutritional intervention
EXPERIMENTALNutritional intervention based on the Brazilian Dietary Guidelines
Interventions
7 individual sessions (online) + 6 small group sessions (1-in person + 5 online)
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of Bipolar disorder types I and II diagnosis
- Adults of both genders, from 18 to 60 years old
- In typical pharmacotherapy for BD, for at least one month
- Agreement to participate in the study with signature of the consent form
You may not qualify if:
- Patients with "very good or excellent" diet quality assessed by the diet quality scale (ESQUADA): \>275 out of a score of 375
- Patients in a state of hypomania or mania: score \>8 (Young Mania Rating Scale - YMRS)
- Patients with severe depression \>21 Montgomery-Åsberg Depression Rating Scale
- Patients at low cardiovascular risk (\<7 points for men or \<9 points for women on the Framingham Global Risk Score)
- Low weight or eutrophic body mass index: \<25kg/m² as in similar studies
- Pregnant or breastfeeding women
- Patients diagnosed with anorexia and bulimia nervosa
- Patientes diagnosed with Irritable Bowl Syndrome or other diagnosed conditions that affect the gastrointestinal function
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Sao Paulolead
- Deakin Universitycollaborator
Study Sites (1)
Fernanda Gabriel
São Paulo, São Paulo, 04514102, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associated professor
Study Record Dates
First Submitted
June 17, 2024
First Posted
July 5, 2024
Study Start
April 1, 2026
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
December 1, 2027
Last Updated
March 2, 2026
Record last verified: 2026-02